Nicole Lea Muraca LMSW

Recommended Articles

• Cardiac Magnetic Resonance Imaging: Helping Muscular Dystrophy Patients with Oedema-Fibrosis

  Duchenne muscular dystrophy (DMD) is a genetic muscular disorder that targets the muscles and causes them to degenerate and weaken. Statistically, around 15,000 males are affected by the condition in the U.S. alone and approximately 300,000 around the world [1]. The most common and severe form of a...

• Treatments for Bronchitis During Pregnancy

  Although bronchitis can be a harmful illness to those who suffer from it, pregnant women may be more severely affected by the symptoms of bronchitis. Bronchitis can cause fetal complications for pregnant women who require constant oxygen levels to stay healthy. Since pregnancy weakens women's...

• What are the Symptoms of Genital Warts?

  Genital warts are small and large growths that are bumpy and appear on the skin of genital areas. They are sexually transmitted and are caused by human papillomaviruses (HPVs). The warts can spread from genital areas to other parts of the body and vice-versa. Some genital warts are too small to be...

• Can Certain Lifestyle Choices Influence the Symptoms of Multiple Sclerosis?

  Multiple sclerosis (MS) is an illness that affects the body’s nervous system and whose cure has yet to be found. MS is characterized by varying signs and symptoms depending on which part of the nervous system is affected. The main and most common signs and symptoms observable in most patients...

• Prenatal Testing and Diagnosis of Cystic Fibrosis

  Cystic fibrosis (CF) is an inherited disease that is caused by a defect in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The CFTR protein is responsible for controlling the transportation of salt in and out of cells. Any mutations in the CFTR gene can cause an imbalance in the...

• New Treatment for Celiac Disease Using Nanoparticles Is Underway

  Recently, investigators have found a potential way to develop a treatment for celiac disease, which, according to Cour Pharmaceuticals focuses on the autoimmune disease, along with other inflammatory diseases. The treatment has been approved for clinical trials in August, 2017, and these trials have...